Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "Response To Interferon Therapy"

ADD TO MY LIST
 
Antiviral therapy in HCV-infected decompensated cirrhotics

Author(s): Danish Fazal | Koul Salman | Subhani Fazal | Rabbani Ahmed | Yasmin Saeeda
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Author(s): Bernard Escudier | Jan Cosaert | Sangeeta Jethwa
Managing pediatric hepatitis C: current and emerging treatment options

Author(s): Wikrom Karnsakul | Mary Kay Alford | Kathleen B Schwarz
Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon

Author(s): Tomofumi Miura, Nobuaki Suzuki, Junichiro Nakamura, Satoshi Yamada, Tsutomu Miura, Masahiko Yanagi, Hiroyuki Usuda, Iwao Emura, Toru Takahashi
New means to monitor the effect of glucocorticoid therapy in children

Author(s): Hanne Rintamäki, Harri M Salo, Outi Vaarala, Kaija-Leena Kolho
Microalbuminuria in hepatitis C-genotype 4: Effect of pegylated interferon and ribavirin

Author(s): Moutaz Derbala, Fatma M Shebl, Awad Rashid, Aliaa Amer, Abdulbari Bener
Infection with hepatitis C virus genotype 3 - Experience of a tertiary health care centre in south India

Author(s): David J | Rajasekar A | Daniel H.D.D | Ngui S | Ramakrishna B | Zachariah U | Eapen C | Abraham P
Recent Advances in the Management of Multiple Sclerosis

Author(s): Carlo Pozzilli | Luca Prosperini
The bevacizumab experience in advanced renal cell carcinoma

Author(s): Lauren C Harshman | Sandy Srinivas
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa

Author(s): Wang Shaoyang | Huang Dedong | Sun Shunlai | Ma Weimin | Zhen Qin
An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients

Author(s): Ali Liaqat | Idrees Muhammad | Ali Muhammad | Rehman Irshad-ur | Hussain Abrar | Afzal Samia | Butt Sadia | Saleem Sana | Munir Saira | Badar Sadaf
Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C

Author(s): Mosaburo Kainuma, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Takeaki Satoh, Toshihiro Maruyama, Makoto Nakamuta, Kazuhiro Kotoh, Koichi Azuma, Junya Shimono, Shinji Shimoda, Jun Hayashi, The Kyushu University Liver Disease Study Group
Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: A phase II study

Author(s): Annagiulia Gramenzi, Carmela Cursaro, Marzia Margotti, Clara Balsano, Alessandra Spaziani, Simona Anticoli, Elisabetta Loggi, Maddalena Salerno, Silvia Galli, Giuliano Furlini, Mauro Bernardi, Pietro Andreone
Hepatitis C virus and type 2 diabetes

Author(s): Francesco Negro, Mahnaz Alaei
Treatment of chronic hepatitis B

Author(s): G. Montazeri | M. R. Ghadir | Rohban M | Estakhri A
Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment

Author(s): Nuntra Suwantarat, Alan D. Tice, Thana Khawcharoenporn, Dominic C. Chow
Current Management of Advanced and Metastatic Renal Cell Carcinoma

Author(s): M Hamad Ather | Nehal Masood | Tahmeena Siddiqui
Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy

Author(s): Al-Qahtani Ahmed | Kessie George | Cruz Damian | Al-Faleh Faleh | Al-Ahdal Mohammed
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899

Author(s): DiPaola Robert | Chen Yu-Hui | Stein Mark | Vaughn David | Patrick-Miller Linda | Carducci Michael | Roth Bruce | White Eileen | Wilding George
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

Author(s): Mecenate Fabrizio | Pellicelli Adriano | Barbaro Giuseppe | Romano Mario | Barlattani Angelo | Mazzoni Ettore | Bonaventura Maria | Nosotti Lorenzo | Arcuri Pasquale | Picardi Antonio | Barbarini Giorgio | D'Ambrosio Cecilia | Paffetti Amerigo | Andreoli Arnaldo | Soccorsi Fabrizio
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

Author(s): Eton Omar | Ross Merrick | East Mary | Mansfield Paul | Papadopoulos Nicholas | Ellerhorst Julie | Bedikian Agop | Lee Jeffrey
Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C

Author(s): Amina Nadeem | Muhammad Mazhar Hussain | Muhammad Aslam | Tassawar Hussain
Beta-interferons in multiple sclerosis: A single center experience in India

Author(s): Gupta Salil | Varadarajulu R | Ganjoo R
Interferon alpha-2b in genital warts

Author(s): Panja SK | Chowdhury A | Banerjee PK | Coondoo A | Nandi S | Saha NCH | Das H.
Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis

Author(s): Liu Qing | Bengmark Stig | Qu Shen
Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children

Author(s): Connell Tom | Davies Mary-Ann | Johannisen Christine | Wood Kathryn | Pienaar Sandy | Wilkinson Katalin | Wilkinson Robert | Zar Heather | Beatty David | Nicol Mark | Curtis Nigel | Eley Brian
Characterization of Treatment Response to Recombinant Interferon-α2b in Osteosarcoma Xenografts

Author(s): Christoph R Müller | Heidi M Namløs | Johan Bjerner | Ingrid HG Østensen | Gunnar Saeter
Interferon-λ in HCV Infection and Therapy  

Author(s): Nicole E. Pagliaccetti | Michael D. Robek
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Author(s): Gonçales Fernando | Moma Camila | Vigani Aline | Angerami Adriana | Gonçales Eduardo | Tozzo Raquel | Pavan Maria | Gonçales Neiva
Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report

Author(s): Conti Maria | Sanna Francesca | Farci Giulia | Uda Sabrina | Porcu Giovanna | Collu Maria | Bonatesta Rosa | Batetta Barbara
Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft

Author(s): Surajit Karmakar | Subhasree Roy Choudhury | Naren L. Banik | Swapan K. Ray
The effect of combined chemotherapy with or without potentiation with interferon alpha or tamoxifen for melanoma

Author(s): Pejčić Ivica | Vrbić Svetislav | Filipović Slađana | Pejčić Ljiljana | Jovanović Bratislav | Šćekić Mirjana | Filipović Aleksandra
Sequence variability at the internal ribosome entry site of the HCV genome in relation to therapy outcome

Author(s): Jovanović-Ćupić Snežana | Simonović-Babić Jasmina | Blagojević Jelena | Božić Milena | Ješić Rada | Nožić D. | Stamenković Gorana
Immunotherapy and Therapeutic antibodies

Author(s): Mayank Gupta | Mujapara A.K | Nikhil Gupta | Soham Trivedi | Prasad Patil | Girish Gupta | Bhrugesh Joshi | Yogesh Khairnar | Vamsi Krishna K | Amol Boraste | Jadhav Amol
Late onset of severe thrombocytopenia during interferon treatment for chronic hepatitis C infection: Case report

Author(s): Hajder Jelena | Stanisavljević Nataša | Marković Olivera | Marisavljević Dragomir
Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users

Author(s): Ružić Maja | Fabri Milotka | Klašnja Biljana | Pobor Marta | Švarc Daniela | Jovelić Aleksandra | Fabri Izabela
Treatment of chronic hepatitis C with pegylated-interferon

Author(s): Fabri Milotka J. | Božić Milena | Delić Dragan | Ješić Rada | Nožić Darko
Effects of interferons on hepatitis C virus infection

Author(s): Bojić Ivanko | Dokić Ljubiša | Minić Svetlana
The role of interferon in the treatment of acute hepatitis C

Author(s): Simonović-Babić Jasmina | Delić Dragan | Švirtlih Neda
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

Author(s): Gogas Helen | Dafni Urania | Koon Henry | Spyropoulou-Vlachou Maria | Metaxas Yannis | Buchbinder Elizabeth | Pectasides Eirini | Tsoutsos Dimosthenis | Polyzos Aristidis | Stratigos Alexandros | Markopoulos Christos | Panagiotou Petros | Fountzilas George | Castana Ourania | Skarlos Pantelis | Atkins Michael | Kirkwood John
Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

Author(s): Murakami Yoshiki | Tanaka Masami | Toyoda Hidenori | Hayashi Katsuyuki | Kuroda Masahiko | Tajima Atsushi | Shimotohno Kunitada
USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

Author(s): Paola Mancino | Katia Falasca | Claudio Ucciferri | Eligio Pizzigallo | Jacopo Vecchiet
Managing hepatitis C in liver transplant patients with recurrent infection

Author(s): Tim Zimmermann | Gerd Otto | Marcus Schuchmann
CHRONIC HEPATITIS C; RESPONSE TO INTERFERON AND RIBAVIRIN COMBINATION

Author(s): SHAUKAT ALI | SYED KHURRAM SHAHZAD
Prevalence and Clinical Relevance of Serum Autoantibodies in Patients with Chronic Hepatitis C

Author(s): Chih-Hung Chen | Chuan-Mo Lee | Chien-Hung Chen | Tsung-Hui Hu | Jing-Houng Wang | Chao-Hung Hung | Ching-Hu Chung | Sheng-Nan Lu
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis

Author(s): Francesco Giuseppe Foschi | Anna Chiara Dall’Aglio | Arianna Lanzi | Giorgio Marano | Sara Savini | Pietro Andreone | Mauro Bernardi | Giuseppe Francesco Stefanini
Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery

Author(s): Steinstraesser Lars | Sorkin Michael | Jacobsen Frank | Al-Benna Sammy | Kesting Marco | Niederbichler Andreas | Otte Jan-Michel | Hirsch Tobias | Stupka Jadwiga | Steinau Hans-Ulrich | Schulte Matthias
Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients

Author(s): Afzal Samia | Idrees Muhammad | Akram Madiha | Awan Zunaira | Khubaib Bushra | Aftab Mahwish | Fatima Zareen | Badar Sadaf | Hussain Abrar
Peginterferon and ribavirin treatment for hepatitis C virus infection

Author(s): Akihito Tsubota, Kiyotaka Fujise, Yoshihisa Namiki,Norio Tada
Hepatitis C Virus Genotypes: Clinical Relevance and Therapeutic Implications

Author(s): Chuan-Mo Lee | Chao-Hung Hung | Sheng-Nan Lu | Chi-Sin Changchien
Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B

Author(s): Ji Chen, Yan Wang, Xue-Jie Wu, Jun Li, Feng-Qin Hou, Gui-Qiang Wang.
On-treatment predictions of success in peg-interferon/ribavirin treatment using a novel formula

Author(s): Hidetsugu Saito, Hirotoshi Ebinuma, Keisuke Ojiro, Kanji Wakabayashi, Mika Inoue, Shinichiro Tada, Toshifumi Hibi
Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease

Author(s): Hanne Rintamäki, Taina Sipponen, Harri M Salo, Outi Vaarala, Kaija-Leena Kolho
Immediate virological response predicts the success of short-term peg-interferon monotherapy for chronic hepatitis C

Author(s): Masayoshi Yada, Akihide Masumoto, Naoki Yamashita, Kenta Motomura, Toshimasa Koyanagi, Shigeru Sakamoto
Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C

Author(s): Jerzy Jaroszewicz, Magdalena Rogalska, Iwona Flisiak, Robert Flisiak
Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response

Author(s): Gerd Bodlaj, Rainer Hubmann, Karim Saleh, Tatjana Stojakovic, Georg Biesenbach, Jörg Berg
Hepatitis B virus infection and renal transplantation

Author(s): Ming-Chao Tsai, Yen-Ta Chen, Yu-Shu Chien, Te-Chuan Chen, Tsung-Hui Hu
Precise prediction model and simplified scoring system for sustained combined response to interferon-α

Author(s): Qian-Guo Mao, Jin-Shui Pan, Kuang-Nan Fang, Ru-Mian Zhang, Qing-Yang Hong, Min-Ning Song, Jian-Ping Zhu, Wen-Qi Huang, Li-Min Chen, Mei-Zhu Hong
Positional effect of mutations in 5'UTR of hepatitis C virus 4a on patients' response to therapy

Author(s): Mostafa K El Awady, Hassan M Azzazy, Ahmed M Fahmy, Sherif M Shawky, Noha G Badreldin, Samar S Yossef, Moataza H Omran, Abdel Rahman N Zekri, Said A Goueli
APRI as a predictor of early viral response in chronic hepatitis C patients

Author(s): José A Mata-Marín, José L Fuentes-Allen, Jesús Gaytán-Martínez, Bulmaro Manjarrez-Téllez, Alberto Chaparro-Sánchez, Carla I Arroyo-Anduiza
Efficacy and safety of pegylated-interferon -2a in hemodialysis patients with chronic hepatitis C

Author(s): Celal Ayaz, Mustafa Kemal Celen, Ugur Nedim Yuce, Mehmet Faruk Geyik
Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C

Author(s): Deepak Kumar, Abdul Malik, Mohammad Asim, Anita Chakravarti, Rakha H Das, Premashis Kar
Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients

Author(s): Hai-Ying Lu, Li-Wei Zhuang, Yan-Yan Yu, Chong-Wen Si, Jun Li, Jian-Jun Zhang, Zheng Zeng, Xin-Yue Chen, Zhong-Hou Han, Yong Chen
Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population

Author(s): Bader Faiyaz Zuberi, Faisal Faiyaz Zuberi, Sajjad Ali Memon, Muhammad Hafeez Qureshi, Sheikh Zafar Ali, Salahuddin Afsar
Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

Author(s): Takayuki Kogure, Yoshiyuki Ueno, Koji Fukushima, Futoshi Nagasaki, Yasuteru Kondo, Jun Inoue, Yasunori Matsuda, Eiji Kakazu, Takeshi Yamamoto, Hiroyoshi Onodera, Yutaka Miyazaki, Hiromasa Okamoto, Takehiro Akahane, Tomoo Kobayashi, Yutaka Mano, Takao Iwasaki, Motoyasu Ishii, Tooru Shimosegawa
Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?

Author(s): Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming

Author(s): Steele Lynette | Errington Fiona | Prestwich Robin | Ilett Elizabeth | Harrington Kevin | Pandha Hardev | Coffey Matt | Selby Peter | Vile Richard | Melcher Alan
Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

Author(s): Liang Minfeng | Ma Shiwu | Hu Xiaoxiong | Zhou Bin | Zhang Junchang | Chen Jinjun | Wang Zhanhui | Sun Jian | Zhu Xiaolin | Abbott William | Hou Jinlin
Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Author(s): Tomiyama Y | Yoshioka N | Yanai Y | Kawase T | Nishina S | Hara Y | Yoshida K | Korenaga K | Korenaga M | Hino K
Extraskeletal effects of vitamin D

Author(s): Maurizio Rossini
Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells

Author(s): Ying Qiu | Ming-Bao Xu | Mark M Yun | Yi-Zhong Wang | Rui-Ming Zhang | Xing-Kai Meng | Xiao-Hui Ou-Yang | Sheng Yun
Insulin resistance and response to interferon and ribavirin therapy in chronic hepatitis type C

Author(s): Marta Wawrzynowicz-Syczewska | Igor Miroszniczenko | Łukasz Laurans | Krzysztof Jurczyk | Ewa Karpińska | Anna Boroń-Kaczmarska
Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients

Author(s): Abdulrahman A Aljumah | Mohamed A Saeed | Ahmed I Al Flaiw | Ibrahim H Al Traif | Abduljaleel M Al Alwan | Salem H Al Qurashi | Ghormallah A Al Ghamdi | Fayez F Al Hejaili | Mohammed A Al Balwi | Abdulla A Al Sayyari
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients

Author(s): Saif Abu-Mouch | Zvi Fireman | Jacob Jarchovsky | Abdel-Rauf Zeina | Nimer Assy
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

Author(s): Adriano M Pellicelli | Massimo Marignani | Valerio Zoli | Mario Romano | Aldo Morrone | Lorenzo Nosotti | Giuseppe Barbaro | Antonio Picardi | Umberto Vespasiani Gentilucci | Daniele Remotti | Cecilia D'Ambrosio | Caterina Furlan | Fabrizio Mecenate | Ettore Mazzoni | Ignazio Majolino | Roberto Villani | Arnaldo Andreoli | Giorgio Barbarini
FibroSURE™ and FibroScan® in relation to treatment response in chronic hepatitis C virus

Author(s): Keyur Patel | Mireen Friedrich-Rust | Yoav Lurie | Mircea Grigorescu | Carol Stanciu | Chuan-Mo Lee | Eugene R Schiff | Dieter Häussinger | Michael P Manns | Guido Gerken | Isabelle Colle | Michael Torbenson | Erik Pulkstenis | G Mani Subramanian | John G McHutchison | Stefan Zeuzem
Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4

Author(s): M. Said | M. S. El-Raziky | M. Abdel-Hamid | Y. Saad | M. Hashem | S. Zakaria | M. K. Mohamed | G. Esmat
An immunologic portrait of cancer

Author(s): Ascierto Maria | Giorgi Valeria De | Liu Qiuzhen | Bedognetti Davide | Spivey Tara | Murtas Daniela | Uccellini Lorenzo | Ayotte Ben | Stroncek David | Chouchane Lotfi | Manjili Masoud | Wang Ena | Marincola Francesco
Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response

Author(s): Etoh Reiko | Imazeki Fumio | Kurihara Tomoko | Fukai Kenichi | Fujiwara Keiichi | Arai Makoto | Kanda Tatsuo | Mikata Rintaro | Yonemitsu Yutaka | Yokosuka Osamu
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

Author(s): Muazzam Ambreen | Qureshi Saleem | Mansoor Atika | Ali Lubna | Iqbal Musarrat | Siddiqi Saima | Khan Khalid | Mazhar Kehkashan
Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4

Author(s): M. Said | M. S. El-Raziky | M. Abdel-Hamid | Y. Saad | M. Hashem | S. Zakaria | M. K. Mohamed | G. Esmat
IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

Author(s): Mauricio Venegas | Rodrigo A Villanueva | Katherine González | Javier Brahm
An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation

Author(s): Nikroo Hashemi | Victor Araya | Kashif Tufail | Laxmi Thummalakunta | Eyob Feyssa | Ashaur Azhar | Mumtaz Niazi | Jorge Ortiz
Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: Interferon Resistance analysis via Sequence Alignment

Author(s): Rafique Shazia | Idrees Muhammad | Ilyas Muhammad | Hussain Abrar | Ali Muhammad | Ali Liaqat | Butt Sadia | Afzal Samia | Ur Rehman Irshad | Saleem Sana
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients

Author(s): Akram Madiha | Idrees Muhammad | Zafar Shamail | Hussain Abrar | Butt Sadia | Afzal Samia | Rehman Irshad-ur | Liaqat Ali | Saleem Sana | Ali Muhammad | Butt Azeem
Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy

Author(s): Akram Madiha | Idrees Muhammad | Hussain Abrar | Afzal Samia | Ilyas Muhammad | Zafar Shamail | Aftab Mahwish | Badar Sadaf | Khubaib Bushra
Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein

Author(s): Ali Ijaz | Khan Sanaullah | Attaullah Sobia | Khan Shahid | Khan Jabbar | Siraj Sami | Iqbal Aqib | Swati Zahoor | Idrees Muhammad
The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters

Author(s): Lowery-Nordberg Mary | Eaton Erin | Gonzalez-Toledo Eduardo | Harris Meghan | Chalamidas Kathrine | McGee-Brown Jeanie | Ganta Chaitanya | Minagar Alireza | Cousineau David | Alexander J Steven
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy

Author(s): Kabeer Basirudeen | Raja Alamelu | Raman Balambal | Thangaraj Satheesh | Leportier Marc | Ippolito Giuseppe | Girardi Enrico | Lagrange Philippe | Goletti Delia
Cell subset prediction for blood genomic studies

Author(s): Bolen Christopher | Uduman Mohamed | Kleinstein Steven
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report

Author(s): Hidaka Masaaki | Takatsuki Mitsuhisa | Soyama Akihiko | Miyaaki Hisamitsu | Ichikawa Tatsuki | Nakao Kazuhiko | Kanematsu Takashi | Eguchi Susumu
Efficacy of different doses of 12-month Interferon alfa therapy in patients with HBeAg negative chronic hepatitis B: A randomized trial

Author(s): N. C. Tassopoulos | G. V. Papatheodoridis | Irini Vafiadou | Ioanna Delladetsima | A. Hatzakis
Affiliate Program     

Tango Rapperswil
Tango Rapperswil